Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19.
Clin Infect Dis. 2020 Sep 23:ciaa1443. doi: 10.1093/cid/ciaa1443. Online ahead of print.
Clin Infect Dis. 2020.
PMID: 32964918
Free PMC article.